Senvest Management
11
94M
10
0.41
1
0.09
4
- Areas of investment
Summary
In 1997 was created Senvest Management, which is appeared as VC. The company was established in North America in United States. The main department of described VC is located in the New York.
Among the most successful fund investment fields, there are Pharmaceutical, Biopharma. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Pharmacopeia.
Deals in the range of 5 - 10 millions dollars are the general things for fund. The high activity for fund was in 2005. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2008.
The standard case for the fund is to invest in rounds with 10 partakers. The meaningful sponsors for the fund in investment in the same round are Nite Capital Management, Iroquois Capital, Highbridge Capital Management.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 1
- Exits
- 4
- Rounds per year
- 0.41
- Follow on index
- 0.09
- Investments by industry
- Biotechnology (3)
- Health Care (3)
- Medical Device (2)
- Consumer Electronics (2)
- Manufacturing (2) Show 22 more
- Investments by region
-
- United States (10)
- Israel (1)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 182M
- Group Appearance index
- 1.00
- Avg. company exit year
- 14
- Avg. multiplicator
- 4.51
- Strategy success index
- 0.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Tasso | 16 Dec 2021 | Health Care, Wellness, Medical | Early Stage Venture | 100M | United States, Washington, Seattle |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.